Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3698-3708
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Table 5 Comparison of short-term therapeutic effects between the two groups, n (%)
Group | Cases | CR | PR | SD | PD | Z | P value |
Observation group | 60 | 0 (0.00) | 35 (58.33) | 19 (31.67) | 6 (10.00) | -2.183 | 0.029 |
Control group | 58 | 0 (0.00) | 23 (39.66) | 23 (39.66) | 12 (20.69) |
- Citation: Ding F, Chen RY, Hou J, Guo J, Dong TY. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3698